Is pulmonary fibrosis stem cell therapy China available to international patients?

Yes. Menstrual-blood MSC therapy for pulmonary fibrosis is available through the Boao Lecheng pilot pathway at Shu Lan (Boao) Hospital, subject to medical assessment and current hospital availability.

How much does pulmonary fibrosis stem cell therapy cost in China?

The estimated cost is ¥140,000, or approximately US$20,800, for a course of three injections. Patients should confirm final pricing and inclusions directly with the hospital.

Who may qualify for menstrual-blood MSC therapy for pulmonary fibrosis?

Patients with PF-ILD showing continued progressive fibrosis despite standard treatment may be considered. Final eligibility is determined by the treating medical team after medical review and face-to-face assessment.

Is this pulmonary fibrosis stem cell therapy approved throughout China?

No. The therapy is included in the third batch of approved Boao Lecheng projects in Hainan. This pilot-zone access status does not mean nationwide approval for routine use throughout China.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

Menstrual-Blood MSC Therapy for Pulmonary Fibrosis Stem Cell Therapy China: 2026 International Patient Guide

ChinaCureLink

Fri Aug 28 2026

6 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page